Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis-Reference-Cited by-同舟云学术

Low Concentrations of C5a Complement Receptor Antibodies Are Linked to Disease Activity and Relapse in Antineutrophil Cytoplasmic Autoantibody–Associated Vasculitis

Published:2023-02-22 Issue:5 Volume:75 Page:760-767
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Klapa Sebastian¹^ORCID,Müller Antje²,Koch Andreas³,Kerstein‐Stähle Anja²,Kähler Wataru³,Heidecke Harald⁴,Schinke Susanne²,Huber‐Lang Markus⁵,Nitschke Martin⁶,Pitann Silke²,Augustin Solveig²,Karsten Christian M.⁷,Riemekasten Gabriela²,Lamprecht Peter²^ORCID

Affiliation:

1. Department of Rheumatology and Clinical Immunology, University of Lübeck, Lübeck, Germany, and Institute of Experimental Medicine Christian‐Albrecht University of Kiel c/o German Naval Medical Institute Kronshagen Germany

2. Department of Rheumatology and Clinical Immunology University of Lübeck Lübeck Germany

3. Institute of Experimental Medicine, Christian‐Albrecht University of Kiel c/o German Naval Medical Institute Kronshagen Germany

4. CellTrend GmbH Luckenwalde Germany

5. Department of Orthopaedic Trauma‐, Hand‐, Plastic‐ and Reconstruction Surgery University of Ulm Ulm Germany

6. Department of Internal Medicine I, Transplant Center University of Lübeck Lübeck Germany

7. Institute of Systemic Inflammation Research University of Lübeck Lübeck Germany

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.42410

Reference19 articles.

1. Complement alternative pathway in ANCA-associated vasculitis: Two decades from bench to bedside

2. Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

3. Alternative Complement Pathway Activation Products in Urine and Kidneys of Patients with ANCA-Associated GN

4. C5a Receptor Mediates Neutrophil Activation and ANCA-Induced Glomerulonephritis

5. C5a Receptor (CD88) Blockade Protects against MPO-ANCA GN

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloperoxidase-specific antineutrophil cytoplasmic antibody-associated vasculitis;The Lancet Rheumatology;2024-05

2. Systemischer Lupus erythematodes: Azathioprin schützt vor kognitiven Defiziten;Aktuelle Rheumatologie;2023-11-28

3. Anti-C5aR-Antikörper geben Aufschluss zu AAV-Krankheitsaktivität;Aktuelle Rheumatologie;2023-11-28

4. Autoantibody Profiling and Anti-Kinesin Reactivity in ANCA-Associated Vasculitis;International Journal of Molecular Sciences;2023-10-19

5. Implicaciones patogénicas, pronósticas y terapéuticas del complemento en las vasculitis asociadas a anticuerpo anticitoplasma de neutrófilo con afectación renal;Medicina Clínica;2023-08